Publications by authors named "Ignacio Pelaez"

Claim this Profile
C
Clinical advances and practice updates in genitourinary cancers: a 2024 review from the multidisciplinary Spanish 'Cambados annual meeting'.
Ignacio Peláez, Martín Lázaro-Quintela, Daniel Pérez-Fentes, Emilio Esteban-González, Enrique Gallardo

Clin Transl Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Clinical advances and practice updates in genitourinary cancers: a 2024 review from the multidisciplinary Spanish 'Cambados annual meeting'.
Ignacio Peláez, Martín Lázaro-Quintela, Daniel Pérez-Fentes, Emilio Esteban-González, Enrique Gallardo

Clin Transl Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Final overall survival results and effect of prolonged (≥ 1 year) first-line bevacizumab-containing therapy for metastatic breast cancer in the ATHENA trial.
Ian Smith, Jean-Yves Pierga, Laura Biganzoli, Hernan Cortes-Funes, Christoph Thomssen, Ignacio Pelaez

Breast Cancer Res Treat· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized phase II study of raltitrexed and gefitinib versus raltitrexed alone as second line chemotherapy in patients with colorectal cancer. (1839IL/0143).
José María Viéitez, Manuel Valladares, Ignacio Peláez, Luis de Sande González, Jesús García-Foncillas

Invest New Drugs· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncogenic RAS alters the global and gene-specific histone modification pattern during epithelial-mesenchymal transition in colorectal carcinoma cells.
Ignacio Mazón Peláez, Margarita Kalogeropoulou, Angelo Ferraro, Angeliki Voulgari, Tibor Pankotai

Int J Biochem Cell Biol· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel therapeutic approaches to the treatment of metastatic breast cancer.
Yolanda Fernández, Juan Cueva, Andrés G Palomo, Manuel Ramos, Ana de Juan

Cancer Treat Rev· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis